25 Nov - 16 Dec 2021Warrent exercise
Cessatech A/S is a late-stage clinical company developing evidence-based treatment for children.
The lead asset (CT001) is an analgesic nasal spray for treatment of acute and planned painful procedures in children. The advantages include needle-free administration, being easy to administer, a fast-acting therapeutic effect and, when it has obtained regulatory approval, also being medically approved for children.
The offer in summary
Exercise period:: November25th, 2021– December16th, 2021 3 p.m.
Subscription price:: DKK 10.00
Trading with warrants:: Until December 14th, 2021
About the warrant:: Each warrant of series TO 1 gives the holder the right to subscribe for one (1) new share
Payment day: : Payment and subscription form shall be Nordic Issuing at handnolater than 3 p.m. December16th, 2021.